DENTSPLY SIRONA Inc - Consumables Revenue
DENTSPLY SIRONA Inc - Europe Revenue
DENTSPLY SIRONA Inc - United States Revenue
DENTSPLY SIRONA Inc - Rest of World Revenue
DENTSPLY SIRONA Inc - Technologies and Equipment Total Net Sales ex. PM sales Revenue
DENTSPLY SIRONA Inc - Technologies and Equipment Revenue
Comments (6)
there are only two companies with approved CAR-T cell therapies at this time, and they do create a small sector with new issues and opportunities all their own.
0 Reply (0) Edit Delete
there are other players in this game as well- companies that deal exclusively with the European market but are listed on the NYSE. It would be good to look at the market as a whole rather than driven by the few.
0 Reply (0) Edit Delete
Very exciting developments.
0 Reply (0) Edit Delete
Gilead has a Zacks Rank #1 (Strong Buy).
0 Reply (0) Edit Delete
GILD\'s, KITE should be worth $20 billion by now.
0 Reply (0) Edit Delete
GILD\'s problem, KITE\'s a lead balloon...
0 Reply (0) Edit Delete